Novocure

About Novocure

Novocure is a global oncology company focused on extending survival in some of the most aggressive forms of cancer through innovative cancer therapies like Tumor Treating Fields (TTFields). Their mission is to improve patients' lives by working together with patients, colleagues, and collaborators.

Products & Services

Tumor Treating Fields (TTFields) Therapy:A cancer therapy used for aggressive forms of cancer, including pancreatic cancer and metastatic non-small cell lung cancer, often in combination with other treatments like gemcitabine, nab-paclitaxel, or immune checkpoint inhibitors.

Optune:A treatment associated with TTFields therapy, likely a device or system used for delivering this therapy to patients.

Specialties

Tumor Treating Fields (TTFields) Therapy Cancer Treatment for Aggressive Forms Pancreatic Cancer Therapy Non-Small Cell Lung Cancer Therapy

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 400000000 MR: - FA: 400 million FAN: 400000000	D: 2024-05-02 FD: 2024-05-02	1 investors

Debt Latest

2024-05-02

$400.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

D.J. Stewart

Community Outreach Coordinator

D

DJ Stewart

Skateboarder and Business Owner

E

Erin

Primary Caregiver and Medical Billing Assistant

R

Ryan Lovell

Director Cinematographer

L

Lucas

Skater

W

Wrex Amadeus

View 46 more team members with Pro

Unlock Full Team Directory

Recent News

Novocure Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised